menu
    • menu

    Company profile for Providence Therapeutics

    NEW Drugs in Dev: 4
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Providence Therapeutics is a biotechnology company that develops mRNA vaccines for human use. We manufacture our vaccines in house in Toronto, ON under GMP manufacturing conditions. Our mission is to provide safe and effective medicines for people suffering from diseases with unmet medical needs. At Providence, the patient is always the priority. Our lead program is a personalized mRNA-based vaccine against cancer. Using...
    Providence Therapeutics is a biotechnology company that develops mRNA vaccines for human use. We manufacture our vaccines in house in Toronto, ON under GMP manufacturing conditions. Our mission is to provide safe and effective medicines for people suffering from diseases with unmet medical needs. At Providence, the patient is always the priority. Our lead program is a personalized mRNA-based vaccine against cancer. Using advanced technology, we identify a patient's tumor mutations and develop a therapeutic vaccine that will elicit an immune response against the tumor cells.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Providence TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    Providence Therapeutics Holdings Inc. 661 University Avenue, Suite 1300 Toront...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://providencetherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/providence-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Products Expo

    Natural Products Expo

    Not Confirmed

    envelop Contact Supplier

    Natural Products Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Providence Therapeutics Appoints Leah Goodman To Board
    Providence Therapeutics Appoints Leah Goodman To Board

    05 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/providence-therapeutics-announces-appointment-of-leah-goodman-to-the-board-of-directors-302679637.html

    PR NEWSWIRE
    05 Feb 2026
    Share Share
    Providence Therapeutics Opens Pediatric mRNA Cancer Trial
    Providence Therapeutics Opens Pediatric mRNA Cancer Trial

    04 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/providence-therapeutics-announces-world-first-personalized-pediatric-mrna-cancer-vaccine-trial-302678301.html

    PR NEWSWIRE
    04 Feb 2026
    Share Share
    Everest to continue mRNA ascent alone, ending Providence collab
    Everest to continue mRNA ascent alone, ending Providence collab

    20 Feb 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/everest-continues-mrna-ascent-alone-after-shedding-providence-partnership

    FIERCE BIOTECH
    20 Feb 2024
    Share Share
    Providence Therapeutics Announces Partnership with UHN
    Providence Therapeutics Announces Partnership with UHN

    02 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/02/2681172/0/en/Providence-Therapeutics-Announces-Partnership-with-University-Health-Network-UHN-for-mRNA-Therapeutic-Discovery-and-Development.html

    GLOBENEWSWIRE
    02 Jun 2023
    Share Share
    Providence Therapeutics Appoints Robert Georgantas as President and CTO
    Providence Therapeutics Appoints Robert Georgantas as President and CTO

    01 Feb 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/02/01/2599422/0/en/Providence-Therapeutics-Appoints-Robert-Georgantas-Ph-D-as-President-and-Chief-Technology-Officer.html

    GLOBENEWSWIRE
    01 Feb 2023
    Share Share
    Providence Therapeutics Announces New mRNA Rabies Vaccine Program
    Providence Therapeutics Announces New mRNA Rabies Vaccine Program

    15 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/12/15/2574539/0/en/Providence-Therapeutics-Announces-New-mRNA-Rabies-Vaccine-Program-and-Achievement-of-Preclinical-Proof-of-Concept-Milestone.html

    GLOBENEWSWIRE
    15 Dec 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search